103 related articles for article (PubMed ID: 28670953)
21. Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD).
Guney E; Ceylan MF; Kara M; Tekin N; Goker Z; Senses Dinc G; Ozturk O; Eker S; Kizilgun M
Neurosci Lett; 2014 Feb; 560():107-11. PubMed ID: 24361544
[TBL] [Abstract][Full Text] [Related]
22. Dynamic thiol/disulfide homeostasis in children with attention deficit hyperactivity disorder and its relation with disease subtypes.
Avcil S; Uysal P; Avcil M; Alışık M; Biçer C
Compr Psychiatry; 2017 Feb; 73():53-60. PubMed ID: 27915219
[TBL] [Abstract][Full Text] [Related]
23. Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder.
Diler RS; Uguz S; Seydaoglu G; Erol N; Avci A
Bipolar Disord; 2007 May; 9(3):243-51. PubMed ID: 17430299
[TBL] [Abstract][Full Text] [Related]
24. Co-morbidity of bipolar disorder in children and adolescents with attention deficit/hyperactivity disorder (ADHD) in an outpatient Turkish sample.
Lus G; Mukaddes NM
World J Biol Psychiatry; 2009; 10(4 Pt 2):488-94. PubMed ID: 19401947
[TBL] [Abstract][Full Text] [Related]
25. Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.
Bilgiç A; Toker A; Uysal S
Psychiatry Clin Neurosci; 2016 Oct; 70(10):442-447. PubMed ID: 27283127
[TBL] [Abstract][Full Text] [Related]
26. Increased Serum Hepcidin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
Yazici KU; Yazici IP; Ustundag B
Clin Psychopharmacol Neurosci; 2019 Feb; 17(1):105-112. PubMed ID: 30690945
[TBL] [Abstract][Full Text] [Related]
27. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders.
Pérez de Los Cobos J; Siñol N; Puerta C; Cantillano V; López Zurita C; Trujols J
Psychiatry Res; 2011 Jan; 185(1-2):205-10. PubMed ID: 20537723
[TBL] [Abstract][Full Text] [Related]
28. Substance abuse disorders in the parents of ADHD children, and parents of normal children.
Farokhzadi F; Mohammadi MR; Alipour A; Rostami R; Dehestani M
Acta Med Iran; 2012; 50(5):319-27. PubMed ID: 22837085
[TBL] [Abstract][Full Text] [Related]
29. Developmental pathways for different subtypes of early-onset bipolarity in youths.
Masi G; Mucci M; Pfanner C; Berloffa S; Magazù A; Perugi G
J Clin Psychiatry; 2012 Oct; 73(10):1335-41. PubMed ID: 23058936
[TBL] [Abstract][Full Text] [Related]
30. Attention deficit and hyperactivity in social anxiety disorder: relationship with trauma history and impulsivity.
Koyuncu A; Çelebi F; Ertekin E; Kök BE; Tükel R
Atten Defic Hyperact Disord; 2016 Jun; 8(2):95-100. PubMed ID: 26797941
[TBL] [Abstract][Full Text] [Related]
31. Attention profiles in childhood absence epilepsy compared with attention-deficit/hyperactivity disorder.
Lee HJ; Kim EH; Yum MS; Ko TS; Kim HW
Brain Dev; 2018 Feb; 40(2):94-99. PubMed ID: 28992996
[TBL] [Abstract][Full Text] [Related]
32. Psychiatric comorbidities in ADHD children: an Iranian study among primary school students.
Amiri S; Shafiee-Kandjani AR; Fakhari A; Abdi S; Golmirzaei J; Akbari Rafi Z; Safikhanlo S
Arch Iran Med; 2013 Sep; 16(9):513-7. PubMed ID: 23981153
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder.
Shim SH; Hwangbo Y; Yoon HJ; Kwon YJ; Lee HY; Hwang JA; Kim YK
Nord J Psychiatry; 2015; 69(7):546-51. PubMed ID: 25753832
[TBL] [Abstract][Full Text] [Related]
34. Attention-deficit/hyperactivity disorder and alexithymia: a pilot study.
Donfrancesco R; Di Trani M; Gregori P; Auguanno G; Melegari MG; Zaninotto S; Luby J
Atten Defic Hyperact Disord; 2013 Dec; 5(4):361-7. PubMed ID: 23864438
[TBL] [Abstract][Full Text] [Related]
35. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
36. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
[TBL] [Abstract][Full Text] [Related]
37. Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.
Richarte V; Corrales M; Pozuelo M; Serra-Pla J; Ibáñez P; Calvo E; Corominas M; Bosch R; Casas M; Ramos-Quiroga JA
Rev Psiquiatr Salud Ment; 2017; 10(4):185-191. PubMed ID: 28844652
[TBL] [Abstract][Full Text] [Related]
38. Psychometric properties of the Farsi translation of the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version.
Ghanizadeh A; Mohammadi MR; Yazdanshenas A
BMC Psychiatry; 2006 Mar; 6():10. PubMed ID: 16539703
[TBL] [Abstract][Full Text] [Related]
39. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
[TBL] [Abstract][Full Text] [Related]
40. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
Todd RD; Huang H; Henderson CA
J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
